Humana
HUM
#1152
Rank
$21.03 B
Marketcap
$174.87
Share price
-3.47%
Change (1 day)
-30.94%
Change (1 year)

P/E ratio for Humana (HUM)

P/E ratio as of February 2026 (TTM): 16.9

According to Humana's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 16.9467. At the end of 2024 the company had a P/E ratio of 25.2.

P/E ratio history for Humana from 2001 to 2025

PE ratio at the end of each year

Year P/E ratio Change
202425.211.81%
202322.60.09%
202222.514.37%
202119.727.13%
202015.5-10.71%
201917.4-21.76%
201822.259.49%
201713.9-69.99%
201646.3138.37%
201519.48.79%
201417.947.17%
201312.148%
20128.21-9.98%
20119.11

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Centene
CNC
-4.01-123.68%๐Ÿ‡บ๐Ÿ‡ธ USA
The Cigna Group
CI
12.4-26.55%๐Ÿ‡บ๐Ÿ‡ธ USA
UnitedHealth
UNH
14.6-13.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Molina Healthcare
MOH
9.60-43.35%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.